ADVFN Logo ADVFN

We could not find any results for:
Make sure your spelling is correct or try broadening your search.

Trending Now

Toplists

It looks like you aren't logged in.
Click the button below to log in and view your recent history.

Sign Up

Already a member? Sign in

Interactive Brokers

Interactive Brokers
Market Data
News
Trading Tools
Markets
Discover

Hot Features

Follow Feed

Connect with traders and investors in our Follow Feed community.

Options Flow

Explore comprehensive options data and use advanced filters with Options Flow.

Monitor

Organize and monitor your stock and asset watchlist with Monitor.
AI Sign In Premium IconPremium Help Menu
S&P 500
5,618.26
-0.29%
US Tech 100
18,927.60
-0.06%
Dow Jones
41,503.10
-0.25%
Brent Oil
72.81
0.59%
Bitcoin
62,014.61
0.56%
Registration Strip Icon for default Register for Free to get streaming real-time quotes, interactive charts, live options flow, and more.
Get Started
  1. Home
  2. Investing
  3. Stocks
  4. USA
  5. NASDAQ

  6. CureVac NV (CVAC) Quote

CureVac NV

CureVac NV (CVAC)

NASDAQ
3.29
0.01
(0.30%)
Closed September 18 4:00PM
Delayed by 15 minutes
3.29
0.00
(0.00%)
After Hours: 7:10PM
Delayed by 15 minutes

Professional-Grade Tools, for Individual Investors.

Premium

Key stats and details

Current Price
3.29
Bid
3.18
Ask
3.47
Volume
310,290
3.21 Day's Range 3.36
2.215 52 Week Range 8.04
Market Cap
736.923M
Previous Close
3.28
Open
3.28
Last Trade
34
@
3.1932
Last Trade Time
Financial Volume
$ 1,027,918
VWAP
3.3128
Average Volume (3m)
812,859
Shares Outstanding
223,988,675
Dividend Yield
-
PE Ratio
-2.82
Earnings Per Share (EPS)
-1.16
Revenue
61.71M
Net Profit
-260.17M

About CureVac NV

CureVac is a biopharmaceutical company headquartered in Germany that is developing vaccines and therapies using messenger ribonucleic acid (mRNA). The company was founded in 2000 and had its initial public offering in August 2020. CureVac is collaborating with GlaxoSmithKline to develop a second-gen... CureVac is a biopharmaceutical company headquartered in Germany that is developing vaccines and therapies using messenger ribonucleic acid (mRNA). The company was founded in 2000 and had its initial public offering in August 2020. CureVac is collaborating with GlaxoSmithKline to develop a second-generation COVID-19 vaccine. CureVac's first attempt to develop a COVID-19 vaccine did not have sufficient efficacy data, and its trials were discontinued in October 2021. The company's other pipeline candidates include mRNA vaccines for influenza, rabies, and malaria. Additionally, CureVac is in the early stages of development for oncology and molecular therapies spanning tumors, liver, ocular, and lung diseases. Show more

Sector
Pharmaceutical Preparations
Industry
Pharmaceutical Preparations
Website
www.curevac.com
Headquarters
Tubingen, Deu
Founded
-
CureVac NV is listed in the Pharmaceutical Preparations sector of the NASDAQ with ticker CVAC. The last closing price for CureVac NV was $3.28. Over the last year, CureVac NV shares have traded in a share price range of $ 2.215 to $ 8.04.

CureVac NV currently has 223,988,675 shares outstanding. The market capitalization of CureVac NV is $734.68 million. CureVac NV has a price to earnings ratio (PE ratio) of -2.82.

Ask ADVFN Intelligence (AI)

CVAC Latest News

More News

Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]

September 13 2024
Edgar (US Regulatory)

Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]

September 12 2024
Edgar (US Regulatory)

Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]

September 09 2024
Edgar (US Regulatory)

Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]

August 15 2024
Edgar (US Regulatory)

Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]

August 15 2024
Edgar (US Regulatory)

Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]

August 15 2024
Edgar (US Regulatory)

Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]

August 15 2024
Edgar (US Regulatory)

Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]

July 11 2024
Edgar (US Regulatory)

Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]

May 28 2024
Edgar (US Regulatory)

Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]

May 24 2024
Edgar (US Regulatory)
PeriodChangeChange %OpenHighLowAvg. Daily VolVWAP
10.278.940397350993.023.442.91014933213.3020863CS
4003.293.442.6954691493.12958113CS
12-0.24-6.798866855523.533.872.6958128593.31481987CS
26-0.01-0.303030303033.35.282.2159880233.45087248CS
52-4.75-59.079601998.048.042.2159424643.96419618CS
156-49.18-93.729750333552.4758.362.21574189511.39833857CS
260-81.7-96.128956347884.991332.21581184434.33322968CS

Movers

View all
  • Most Active
  • % Gainers
  • % Losers
SymbolPriceVol.
OMEXOdyssey Marine Exploration Inc
$ 1.39
(180.07%)
328.86M
PRTGPortage Biotech Inc
$ 9.7581
(115.41%)
51.53M
APLTApplied Therapeutics Inc
$ 7.86
(69.03%)
51.66M
XCHXCHG Ltd
$ 18.40
(65.77%)
1.26M
WBUYWeBuy Global Ltd
$ 0.1867
(60.95%)
247.93M
GLMDGalmed Pharmaceuticals Ltd
$ 6.83
(-54.77%)
6.24M
KAKineta Inc
$ 0.5691
(-31.35%)
530.74k
DTSSDatasea Inc
$ 2.07
(-29.59%)
1.34M
CBUSCibus Inc
$ 3.595
(-28.95%)
2.31M
BFIBurgerFi International Inc
$ 0.1705
(-26.98%)
16.55M
OMEXOdyssey Marine Exploration Inc
$ 1.39
(180.07%)
328.86M
NVDANVIDIA Corporation
$ 113.37
(-1.92%)
310.12M
WBUYWeBuy Global Ltd
$ 0.1867
(60.95%)
247.93M
SQQQProShares UltraPro Short QQQ
$ 8.40
(1.45%)
200.53M
LUNRIntuitive Machines Inc
$ 7.4512
(37.99%)
141.82M

CVAC Discussion

View Posts
Monksdream Monksdream 2 weeks ago
CVAC under $4
👍️0
tw0122 tw0122 4 months ago
There is a cure again
👍️0
Monksdream Monksdream 5 months ago
CVAC new 52 week low
👍️0
Monksdream Monksdream 5 months ago
CVAC new 52 week low
👍️0
Monksdream Monksdream 7 months ago
CVAC new 52 week low
👍️0
Monksdream Monksdream 7 months ago
CVAC new 52 week low
👍️0
mick mick 9 months ago
https://www.otcmarkets.com/stock/CVAC
👍️0
mick mick 9 months ago
https://www.otcmarkets.com/stock/CVAC
👍️0
mick mick 10 months ago
https://www.otcmarkets.com/stock/CVAC
👍️0
mick mick 12 months ago
https://www.otcmarkets.com/stock/CVAC
👍️0
mick mick 12 months ago
https://www.otcmarkets.com/stock/CVAC
👍️0
mick mick 1 year ago
CVAC
CureVac NV
8.99
0.09 (1.01%)
Volume: 232,857
Day Range: 8.73 - 9.15
Last Trade Time: 6:30:54 PM EDT
👍️0
Mr. Pearson Mr. Pearson 1 year ago
Big News coming soon... just be patient....
👍️0
mick mick 1 year ago
CVAC
CureVac NV
10.98
1.30 (13.43%)
Volume: 464,848
Day Range: 9.72 - 10.47
Last Trade Time: 7:53:28 PM EDT
👍️0
mick mick 1 year ago
CVAC
CureVac NV
10.98
1.30 (13.43%)
Volume: 464,848
Day Range: 9.72 - 10.47
Last Trade Time: 7:53:28 PM EDT
👍️0
mick mick 1 year ago
CVAC
CureVac NV
10.98
1.30 (13.43%)
Volume: 464,848
Day Range: 9.72 - 10.47
Last Trade Time: 7:53:28 PM EDT
👍️0
mick mick 1 year ago
CVAC
CureVac NV
12.23
0.80 (7.00%)
Volume: 2,433,695
Day Range: 11.02 - 12.36
Last Trade Time: 7:59:28 PM EDT
👍️0
mick mick 1 year ago
CVAC
CureVac NV
12.23
0.80 (7.00%)
Volume: 2,433,695
Day Range: 11.02 - 12.36
Last Trade Time: 7:59:28 PM EDT
👍️0
mick mick 1 year ago
CVAC
CureVac NV
9.15
-0.28 (-2.97%)
Volume: 373,244
Day Range: 9.06 - 9.49
Last Trade Time: 6:38:15 PM EDT
👍️0
mick mick 1 year ago
CVAC
CureVac NV
7.37
0.05 (0.68%)
Volume: 613,302
Day Range: 7.28 - 7.40
Last Trade Time: 7:50:44 PM EDT
👍️0
mick mick 1 year ago
CVAC
CureVac NV
7.79
-0.11 (-1.39%)
Volume: 227,150
Day Range: 7.66 - 8.13
Last Trade Time: 5:09:42 PM EDT
👍️0
mick mick 1 year ago
CVAC
CureVac NV
7.79
-0.11 (-1.39%)
Volume: 227,150
Day Range: 7.66 - 8.13
Last Trade Time: 5:09:42 PM EDT
👍️0
mick mick 1 year ago
CVAC
CureVac NV
7.79
-0.11 (-1.39%)
Volume: 227,150
Day Range: 7.66 - 8.13
Last Trade Time: 5:09:42 PM EDT
👍️0
mick mick 1 year ago
CVAC
CureVac NV
7.79
-0.11 (-1.39%)
Volume: 227,150
Day Range: 7.66 - 8.13
Last Trade Time: 5:09:42 PM EDT
👍️0
mick mick 2 years ago
CVAC
CureVac NV
8.50
-0.16 (-1.85%)
Volume: 641,450
Day Range: 8.52 - 8.68
Last Trade Time: 7:00:46 PM EST
👍️0
mick mick 2 years ago
CVAC
CureVac NV
11.06
-0.62 (-5.31%)
Volume: 537,147
Day Range: 11.01 - 11.83
Last Trade Time: 7:55:22 PM EST
👍️0
mick mick 2 years ago
it is relative CureVac (CVAC) Receives a Buy from Berenberg Bank
August 23 2022 - 09:55PM
TipRanks
Alert
Print
Share On Facebook
In a report released yesterday, Zhiqiang Shu from Berenberg Bank maintained a Buy rating on CureVac (CVAC - Research Report), with a price target of $45.00. The company's shares closed yesterday at $11.32.Shu covers the Healthcare sector, focusing on stocks such as Alnylam Pharma, Arcus Biosciences, and Sutro Biopharma. According to TipRanks, Shu has an average return of -21.0% and a 23.78% success rate on recommended stocks. Currently, the analyst consensus on CureVac is a Moderate Buy with an average price target of $28.50, implying a 151.77% upside from current levels.
https://www.tipranks.com/news/blurbs/curevac-cvac-receives-a-buy-from-berenberg-bank?utm_source=advfn.com&utm_medium=referral
👍️0
mick mick 2 years ago
CVAC
CureVac NV
6.60
-0.21 (-3.08%)
Volume: 387,429
Day Range: 6.58 - 6.99
Last Trade Time: 4:09:13 PM EST
👍️0
mick mick 2 years ago
i think $CVAC is ah buyout candidate /\

let's say $40
👍️0
mick mick 2 years ago
CVAC
CureVac NV
6.81
0.04 (0.59%)
Volume: 1,065,479
Day Range: 6.52 - 6.93
Last Trade Time: 4:46:47 PM EST
👍️0
mick mick 2 years ago
CVAC
CureVac NV
7.49
0.28 (3.88%)
Volume: 181,787
Day Range: 7.155 - 7.49
Bid: 6.13
Ask: 9.18
Last Trade Time: 4:13:18 PM EDT
Total Trades: 1,819
CVAC Detailed Quote
👍️0
mick mick 2 years ago
CVAC
CureVac NV
7.49
0.28 (3.88%)
Volume: 181,787
Day Range: 7.155 - 7.49
Bid: 6.13
Ask: 9.18
Last Trade Time: 4:13:18 PM EDT
Total Trades: 1,819
CVAC Detailed Quote
👍️0
mick mick 2 years ago
CVAC
CureVac N.V.
Ordinary Shares
9.84
-0.40

-3.90%

Delayed (15 Min) Trade Data: 04:00pm 08/31/2022
Overview
Quote
Company Profile
Security Details
News
Financials
Disclosure
Research
👍️0
mick mick 2 years ago
we don't show quote ?????
👍️0
mick mick 2 years ago
we don't show quote ?????
👍️0
mick mick 2 years ago
CureVac (CVAC) Receives a Buy from Berenberg Bank
August 23 2022 - 09:55PM
TipRanks
Alert
Print
Share On Facebook
In a report released yesterday, Zhiqiang Shu from Berenberg Bank maintained a Buy rating on CureVac (CVAC - Research Report), with a price target of $45.00. The company's shares closed yesterday at $11.32.Shu covers the Healthcare sector, focusing on stocks such as Alnylam Pharma, Arcus Biosciences, and Sutro Biopharma. According to TipRanks, Shu has an average return of -21.0% and a 23.78% success rate on recommended stocks. Currently, the analyst consensus on CureVac is a Moderate Buy with an average price target of $28.50, implying a 151.77% upside from current levels.
https://www.tipranks.com/news/blurbs/curevac-cvac-receives-a-buy-from-berenberg-bank?utm_source=advfn.com&utm_medium=referral
👍️0
mick mick 2 years ago
CVAC
CureVac NV
12.62
-0.03 (-0.24%)
Volume: 276,718
Day Range: 12.39 - 12.79
Bid: 12.60
Ask: 13.18
Last Trade Time: 4:57:18 PM EDT
Total Trades: 3,775
CVAC Detailed Quote
👍️0
sdy sdy 2 years ago
Interesting new Beneficial Owners recently. Taken an entry position today.
Looks like Covid-19 vaccines still hold prominent place in biotech research: "CureVac and GSK's second-generation vaccine candidate targeting two recent COVID-19 variants has been shown to be highly effective in preclinical studies on mice, CureVac said, as it seeks to catch up with rivals' development work." https://finance.yahoo.com/news/1-curevac-gsks-experimental-covid-124419805.html
👍️0
mick mick 2 years ago
CureVac NV (CVAC)
18.18 ? -0.65 (-3.45%)
Volume: 402,327 @06/03/22 6:58:05 PM EDT
Bid Ask Day's Range
17.61 20.1 17.56 - 18.58
CVAC Detailed Quote
👍️0
mick mick 2 years ago
CureVac NV (CVAC)
18.18 ? -0.65 (-3.45%)
Volume: 402,327 @06/03/22 6:58:05 PM EDT
Bid Ask Day's Range
17.61 20.1 17.56 - 18.58
CVAC Detailed Quote
👍️0
mick mick 2 years ago
https://www.tipranks.com/news/blurbs/analysts-top-healthcare-picks-contrafect-cfrx-curevac-cvac?utm_source=advfn.com&utm_medium=referral
👍️0
mick mick 2 years ago
https://www.tipranks.com/news/blurbs/analysts-top-healthcare-picks-contrafect-cfrx-curevac-cvac?utm_source=advfn.com&utm_medium=referral
👍️0
mick mick 2 years ago
CureVac NV (CVAC)
17.205 ? 0.625 (3.77%)
Volume: 164,845 @04/29/22 1:27:43 PM EDT
Bid Ask Day's Range
17.2 17.25 16.47 - 17.44
CVAC Detailed Quote
👍️0
mick mick 3 years ago
CureVac NV (CVAC)
15.69 ? -1.08 (-6.44%)
Volume: 305,719 @03/11/22 5:11:50 PM EST
Bid Ask Day's Range
15.7 16.66 15.68 - 17.225
CVAC Detailed Quote
👍️0
mick mick 3 years ago
CureVac NV (CVAC)
18.19 ? 0.05 (0.28%)
Volume: 587,579 @02/04/22 5:09:58 PM EST
Bid Ask Day's Range
17.05 19.74 17.7685 - 18.61
CVAC Detailed Quote
👍️0
mick mick 3 years ago
https://www.otcmarkets.com/stock/CVAC
👍️0
mick mick 3 years ago
https://www.otcmarkets.com/stock/CVAC
👍️0
2times2 2times2 3 years ago
CureVac Says Preclinical Trial Shows Antibody Levels of COVID-19 Vaccine Candidate CV2CoV 'Highly Comparable' With Pfizer's mRNA Vaccine
MT NEWSWIRES 3:11 PM ET 11/18/2021

03:11 PM EST, 11/18/2021 (MT Newswires) -- CureVac(CVAC) said Thursday the extended preclinical study of the second-generation vaccine candidate, CV2CoV, showed that neutralizing antibody levels after full vaccination of animals were "highly comparable" with Pfizer (PFE) and BioNTech's (BNTX) licensed mRNA vaccine, Comirnaty.

CureVac (CVAC) is developing CV2CoV in partnership with GlaxoSmithKline (GSK). Animals were vaccinated with either 12 micrograms of CV2CoV or a 30 microgram standard dose of Comirnaty.

Data showed that targeted optimizations of a non-chemically modified mRNA can significantly improve immune responses in a preclinical model.

👍️0
mick mick 3 years ago
CureVac NV (CVAC)
38.0 ? -3.47 (-8.37%)
Volume: 1,621,942 @11/05/21 7:55:54 PM EDT
Bid Ask Day's Range
38.02 38.19 36.32 - 39.33
CVAC Detailed Quote
👍️0
mick mick 3 years ago
CureVac NV (CVAC)
38.64 ? -2.83 (-6.82%)
Volume: 1,620,537 @11/05/21 4:05:48 PM EDT
Bid Ask Day's Range
38.0 38.2 36.32 - 39.33
CVAC Detailed Quote
👍️0

Your Recent History

NASDAQ
CVAC
CureVac NV
Delayed Upgrade Clock
ADVFN Logo
InvestorsHub

United States
Company
Business
Popular
Get The App
App Store
Google Play

Support: 1-888-992-3836 | support@advfn.com

By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions

© 2024 ADVFN PLC - All Rights Reserved